DK3773511T3 - Oral tablet til induceret spytproduktion - Google Patents

Oral tablet til induceret spytproduktion Download PDF

Info

Publication number
DK3773511T3
DK3773511T3 DK19729175.0T DK19729175T DK3773511T3 DK 3773511 T3 DK3773511 T3 DK 3773511T3 DK 19729175 T DK19729175 T DK 19729175T DK 3773511 T3 DK3773511 T3 DK 3773511T3
Authority
DK
Denmark
Prior art keywords
oral tablet
saliva production
induced saliva
induced
production
Prior art date
Application number
DK19729175.0T
Other languages
English (en)
Inventor
Helle Wittorff
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66793731&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3773511(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Application granted granted Critical
Publication of DK3773511T3 publication Critical patent/DK3773511T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK19729175.0T 2018-05-17 2019-05-15 Oral tablet til induceret spytproduktion DK3773511T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/982,758 US11096894B2 (en) 2018-05-17 2018-05-17 Oral tablet for induced saliva generation
PCT/DK2019/050152 WO2019219142A1 (en) 2018-05-17 2019-05-15 An oral tablet for induced saliva generation

Publications (1)

Publication Number Publication Date
DK3773511T3 true DK3773511T3 (da) 2022-08-22

Family

ID=66793731

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19729175.0T DK3773511T3 (da) 2018-05-17 2019-05-15 Oral tablet til induceret spytproduktion

Country Status (13)

Country Link
US (1) US11096894B2 (da)
EP (2) EP3773511B1 (da)
JP (1) JP7403476B2 (da)
KR (1) KR20210010856A (da)
CN (1) CN112118834B (da)
AU (1) AU2019269879B2 (da)
BR (1) BR112020023173A2 (da)
CA (1) CA3097055C (da)
DK (1) DK3773511T3 (da)
ES (1) ES2926159T3 (da)
MX (1) MX2020012280A (da)
PL (1) PL3773511T3 (da)
WO (1) WO2019219142A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021268903A1 (en) * 2020-05-08 2022-11-17 Fertin Pharma A/S Oral powder mixture with small sized particles
WO2023241838A1 (de) * 2022-06-14 2023-12-21 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3070510A (en) 1959-11-03 1962-12-25 Procter & Gamble Dentifrice containing resinous cleaning agents
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US3862307A (en) 1973-04-09 1975-01-21 Procter & Gamble Dentifrices containing a cationic therapeutic agent and improved silica abrasive
CA1080024A (en) * 1975-12-24 1980-06-24 Leonard Spooner Confection containing xylitol
US4340583A (en) 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US4820506A (en) 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
US4997654A (en) * 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
GB9100009D0 (en) 1991-01-02 1991-02-20 Cerestar Holding Bv Erythritol compositions
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
TW469135B (en) 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
DK0922464T3 (da) 1996-07-12 2005-06-06 Daiichi Seiyaku Co Hurtigt desintegrerbare, kompressionsstöbte materialer og fremgangsmåder til fremstilling af samme
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
GB9716432D0 (en) 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
EP1047407A4 (en) 1997-12-19 2007-05-02 Smithkline Beecham Corp METHOD FOR PRODUCING A COUTINE TABLET
WO2000025598A1 (en) 1998-11-03 2000-05-11 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
FR2785538B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
IL157320A0 (en) 2001-02-08 2004-02-19 Pharmacia Corp Rapid-onset medicament for the treatment of sexual dysfunction
CN1494419A (zh) 2001-03-06 2004-05-05 协和发酵工业株式会社 口腔内快速崩解制剂
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
AU2003222027A1 (en) * 2002-03-20 2003-10-08 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
CA2512611C (en) 2003-02-04 2012-01-03 Gumlink A/S Compressed chewing gum tablet
AU2005234777B2 (en) 2004-04-20 2009-02-19 Wm. Wrigley Jr. Company Breath freshening confectionery products and methods of making and using same
WO2006034264A2 (en) 2004-09-21 2006-03-30 Applera Corporation Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis
WO2006058250A2 (en) * 2004-11-24 2006-06-01 Spi Pharma, Inc. Orally disintegrating compositions
WO2006112961A2 (en) 2005-03-03 2006-10-26 Takasago International Corp. (Usa) Synergistic salivation components
CN1709229A (zh) 2005-06-10 2005-12-21 北京阜康仁生物制药科技有限公司 盐酸美金刚口腔崩解片及其制备方法
EP1738657A3 (en) 2005-06-28 2007-01-17 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Sugar alcohol composition for tableting
PT2046300E (pt) 2006-08-04 2010-07-01 Ethypharm Sa Comprimido multicamadas de desintegraã†o oral
WO2009007768A1 (en) 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
WO2009016133A1 (en) 2007-07-27 2009-02-05 Cargill, Incorporated Micronization of polyols
WO2009080023A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising peptide
CA2735037C (en) 2008-09-04 2016-07-12 Cargill Incorporated Tabletting of erythritol
AU2010223105B2 (en) 2009-03-09 2016-05-12 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
US8658139B1 (en) 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
CN103384517A (zh) 2010-12-22 2013-11-06 巴斯夫欧洲公司 快速崩解的固体包衣剂型
CN104053431A (zh) 2011-12-22 2014-09-17 费尔廷制药公司 从口香糖中释放烟碱的方法
JP6040218B2 (ja) 2012-02-23 2016-12-07 フロイント産業株式会社 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
WO2013171164A1 (en) 2012-05-14 2013-11-21 EJP Pharmaceutical ApS Compositions and formulations for the treatment of halitosis
AU2014266070A1 (en) 2013-05-17 2015-12-10 Alequident Limited Oral healthcare product
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
CA2963706C (en) 2014-10-16 2023-10-03 Cargill, Incorporated Process for preparing a directly compressible erythritol & uses thereof
AU2015346374A1 (en) 2014-11-11 2017-04-27 Johnson & Johnson Consumer Inc. Amino acid derivatives and their uses
JP7297666B2 (ja) * 2016-11-18 2023-06-26 フェルティン ファルマ アー／エス オーラルケア効果をもたらす方法
US11351103B2 (en) 2016-11-18 2022-06-07 Johnson & Johnson Consumer Inc. Method of providing oral care benefits
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
BR112019007798B1 (pt) 2016-11-18 2023-12-19 Fertin Pharma A/S Comprimido com veículo de liberação oral
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
US11135157B2 (en) 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US11096895B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
JP7214755B2 (ja) 2018-05-17 2023-01-30 フェルティン ファルマ アー／エス 医薬品活性成分に適した錠剤化チューインガム
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
FI3920890T3 (fi) 2019-04-17 2023-11-30 Nordiccan As Oraalinen kannabinoiditabletti

Also Published As

Publication number Publication date
CA3097055C (en) 2022-08-02
JP7403476B2 (ja) 2023-12-22
PL3773511T3 (pl) 2022-10-10
ES2926159T3 (es) 2022-10-24
MX2020012280A (es) 2022-11-17
US20190350859A1 (en) 2019-11-21
BR112020023173A2 (pt) 2021-02-09
EP3773511A1 (en) 2021-02-17
US11096894B2 (en) 2021-08-24
WO2019219142A1 (en) 2019-11-21
CN112118834B (zh) 2024-01-02
AU2019269879A1 (en) 2020-10-22
JP2021524438A (ja) 2021-09-13
CA3097055A1 (en) 2019-11-21
EP4088716A1 (en) 2022-11-16
EP3773511B1 (en) 2022-07-06
KR20210010856A (ko) 2021-01-28
AU2019269879B2 (en) 2022-07-21
CN112118834A (zh) 2020-12-22

Similar Documents

Publication Publication Date Title
DK3383747T3 (da) Fremgangsmåde til at fremstille et oralt poseholdt snusprodukt
DK3634468T3 (da) Fast sammensætning til oral indgivelse
MA44720A (fr) Comprimés à désintégration orale
ES2970393T3 (es) Cemento dental
EP3527200A4 (en) ORAL LENALIDOMIDE TABLET COMPOSITION
DK3920890T3 (da) Oral cannabinoid-tablet
DK3215117T3 (da) Oral dexamethasonfilm
DK3762009T3 (da) Toxin-afledte indgivelseskonstrukter til oral indgivelse
DK3157506T3 (da) Smagsmaskeret oral, farmaceutisk sammensætning
DK3773511T3 (da) Oral tablet til induceret spytproduktion
DK3930663T3 (da) Mundplejeprodukt
MA51009A (fr) Composition de soins buccaux
DK3174533T3 (da) Oral desintegrerende tablet
DK3199040T3 (da) Oral tobakssammensætning og fremstillingsfremgangsmåde deraf
BR112016025242A2 (pt) instrumento de cuidado oral
KR20180084728A (ko) 구강용 조성물
DK3996688T3 (da) Farmaceutisk præparat
DK3908321T3 (da) Farmaceutisk sammensætning
DK3199039T3 (da) Oral tobakssammensætning og fremstillingsfremgangsmåde deraf
DK3774838T3 (da) Lixisenatidsyntese med capping
IT201700068034A1 (it) Impianto dentale endosseo
JP1694619S (ja) 錠剤
UY4585S (es) Comprimidos farmacéuticos
TH191127S (th) เครื่องดูดน้ำลาย
FR3053245B3 (fr) Structure de timbre oral